Medical Condition News

RSS

Seaweed microsponges may help diagnose many diseases quickly, at far lower cost

Microsponges derived from seaweed may help diagnose heart disease, cancers, HIV and other diseases quickly and at far lower cost than current clinical methods. The microsponges are an essential component of Rice University's Programmable Bio-Nano-Chip (PBNC) and the focus of a new paper in the journal Small.

9 Feb 2011

New study: Testosterone administration leads to significant reduction in mind reading

A new study from Utrecht and Cambridge Universities has for the first time found that an administration of testosterone under the tongue in volunteers negatively affects a person's ability to 'mind read', an indication of empathy. The findings are published this week in the journal Proceedings of the National Academy of Sciences.

9 Feb 2011

FDA clears EOS orthopedic imaging system for use in lower limbs applications

EOS imaging announced today that it has received FDA clearance of its sterEOS 3D orthopedic imaging workstation for use in lower limbs applications for patients 15 years and older.

9 Feb 2011

Targacept initiates TC-6987 Phase 2 study in patients with asthma, Type 2 diabetes

Targacept, Inc., a clinical-stage biopharmaceutical company developing novel NNR Therapeutics™, today announced the initiation of separate Phase 2 clinical studies of its product candidate TC-6987 in disorders characterized by inflammation, one in asthma and one in Type 2 diabetes.

9 Feb 2011

PBNC technology may help detect cardiac disease, reduce diagnostic costs

Heart disease is a silent killer, but new microchip technology from Rice University is expected to advance the art of diagnosis.

9 Feb 2011

No effort for ensuring continuity of supports and services as ASD children age into adulthood: Study

What happens to young adults with autism spectrum disorders (ASDs) once they graduate high school and are no longer entitled to services?

9 Feb 2011

NCCN praises Aetna for evidence-based approach to treat cancer

The National Comprehensive Cancer Network® (NCCN) has praised Aetna for its evidence-based approach to drugs used to treat cancer. The NCCN also acknowledged Aetna's commitment to providing health benefits to members enrolled in clinical trials. Aetna is the first national health plan to be recognized by the group.

9 Feb 2011

PolyMedix commences PMX-60056 Phase 2 clinical trial in patients undergoing PCI

PolyMedix, Inc., an emerging biotechnology company focused on developing new therapeutic drugs to treat infectious diseases and acute cardiovascular disorders, has initiated a Phase 2 clinical trial, following conclusion of a review by the United States Food and Drug Administration (FDA) of a protocol submitted by PolyMedix, to assess the safety and efficacy of its heptagonist, PMX-60056, in reversing heparin in patients undergoing Percutaneous Coronary Intervention (PCI) procedures.

9 Feb 2011

CeNeRx announces FDA approval of CXB909 IND for neuroprotection and neurodegenerative disorders

CeNeRx BioPharma, Inc., a clinical-stage company developing and commercializing innovative treatments for diseases of the central nervous system (CNS), today announced FDA approval of its IND and reported the first clinical results in humans for CXB909, a novel agent that has demonstrated utility in preclinical models of neuroprotection and neurodegenerative disorders.

9 Feb 2011

DiaTech, Walter Reed collaborate to determine the best chemotherapy for cancer

DiaTech Oncology announced today they have engaged in a pilot with Walter Reed Army Medical Center to determine the best Chemotherapy for Cancer patients. Medical and GYN Oncologists and from Walter Reed have been working with DiaTech Oncology (Nashville, TN) using the MiCK assay for apoptosis in order to give physicians a tool that can predict the best chemotherapy pathway in treating cancer patients.

9 Feb 2011

Rapid detection of transiently folded single-molecule structures from 'intrinsically disordered proteins'

A team of scientists from The Scripps Research Institute and the University of California, San Diego (UCSD) have developed a novel technique to observe previously unknown details of how folded structures are formed from an intrinsically disordered protein. The insights could help scientists to better understand the mechanism of plaque formation in neurodegenerative disorders such as Parkinson's and Alzheimer's diseases.

9 Feb 2011

QLT's Phase II olopatadine punctal plug delivery system trial demonstrates safety in allergic conjunctivitis patients

QLT Inc. today announced results from a Phase II proof-of-concept clinical trial for the olopatadine punctal plug delivery system (O‑PPDS).

9 Feb 2011

Minor damage to heart muscle during coronary artery bypass grafting associated with increased risk of death

Researchers at Mount Sinai School of Medicine have found that even small amounts of damage to heart muscle during coronary artery bypass grafting (CABG) is associated with an increased risk of death, even among patients who initially do well following surgery. The study is published in the February 9 issue of the Journal of the American Medical Association (JAMA).

9 Feb 2011

Steep reductions in co-pays may not motivate seniors to seek mental health care: Study

Despite the intent of recent mental health "parity" legislation, including the Affordable Care Act, even steep reductions in co-pays for outpatient mental health care will not motivate more seniors in managed care plans to seek that care, according to a new study by Brown University researchers.

9 Feb 2011

Research findings highlight potential for noninvasive MSC delivery to treat Parkinson disease

Successful intranasal delivery of stem cells to the brains of rats with Parkinson disease yielded significant improvement in motor function and reversed the dopamine deficiency characteristic of the disease.

9 Feb 2011

Kaiser Permanente Southern California selected for 10-center Mental Health Research Network

The Kaiser Permanente Southern California Department of Research & Evaluation has been selected for inclusion in the 10-center Mental Health Research Network (MHRN) recently funded with a $10.5 million grant from the National Institute of Mental Health. The five other Kaiser Permanente research centers included in the MHRN are located in Northern California, Oregon, Colorado, Georgia, and Hawaii.

9 Feb 2011

Humira and Enbrel have best overall clinical profile for treatment of moderate to severe psoriasis: Survey

Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that, for the treatment of moderate to severe psoriasis, the highest proportion of surveyed dermatologists and managed care organizations' (MCOs) pharmacy directors indicate that Abbott/Eisai's Humira and Amgen/Pfizer/Stiefel/Takeda's Enbrel have the best overall clinical profile when compared to other currently available agents.

9 Feb 2011

AcademyHealth recognizes military health research study with 2011 HSR Impact Award

AcademyHealth today recognized research that improves access to behavioral health care for returning U.S. service members with the 2011 Health Services Research Impact Award.

9 Feb 2011

DENTSPLY 2010 net sales increase 2.9% to record $2.221 billion

DENTSPLY International Inc. today announced sales and earnings for the three months and year ended December 31, 2010.

9 Feb 2011

Funding too low for paediatric oncology research

At a time when the effects of paediatric oncology research have meant that more and more children survive cancer, its funding is too low and dependent on short-term grants to be able to sustain this improvement in the long-term, says a report supported by the EU-funded 7th Framework Programme project Eurocancercoms and published on-line in ecancer today.

9 Feb 2011

Medical Condition News

Seaweed microsponges may help diagnose many diseases quickly, at far lower cost

New study: Testosterone administration leads to significant reduction in mind reading

FDA clears EOS orthopedic imaging system for use in lower limbs applications

Targacept initiates TC-6987 Phase 2 study in patients with asthma, Type 2 diabetes

PBNC technology may help detect cardiac disease, reduce diagnostic costs

No effort for ensuring continuity of supports and services as ASD children age into adulthood: Study

NCCN praises Aetna for evidence-based approach to treat cancer

PolyMedix commences PMX-60056 Phase 2 clinical trial in patients undergoing PCI

CeNeRx announces FDA approval of CXB909 IND for neuroprotection and neurodegenerative disorders

DiaTech, Walter Reed collaborate to determine the best chemotherapy for cancer

Rapid detection of transiently folded single-molecule structures from 'intrinsically disordered proteins'

QLT's Phase II olopatadine punctal plug delivery system trial demonstrates safety in allergic conjunctivitis patients

Minor damage to heart muscle during coronary artery bypass grafting associated with increased risk of death

Steep reductions in co-pays may not motivate seniors to seek mental health care: Study

Research findings highlight potential for noninvasive MSC delivery to treat Parkinson disease

Kaiser Permanente Southern California selected for 10-center Mental Health Research Network

Humira and Enbrel have best overall clinical profile for treatment of moderate to severe psoriasis: Survey

AcademyHealth recognizes military health research study with 2011 HSR Impact Award

DENTSPLY 2010 net sales increase 2.9% to record $2.221 billion

Funding too low for paediatric oncology research

Discover how SciY empowers scientists

Why use light scattering to analyze proteins and viral vectors?

Changing the landscape of R&D to build clinical success from the ground up

Latest News